ID   Ed147.BT
AC   CVCL_GR70
SY   Ed147
DR   TOKU-E; 4007
DR   Wikidata; Q54831956
RX   PubMed=10448865;
RX   PubMed=10807250;
RX   PubMed=11950413;
CC   Characteristics: Early passage culture.
CC   Karyotypic information: 46,XY [1]; 45,X [4]; 44,X,-8 [1]; 45,XY,-22 [1] (PubMed=10448865).
CC   Caution: Indicated as originating from a 52 year old at sampling in PubMed=11950413 and 57 year old in PubMed=10807250.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
RX   PubMed=10807250; DOI=10.1097/00006123-200005000-00030;
RA   Parney, Ian Frederick
RA   Farr-Jones, Maxine A.
RA   Chang, Lung-Ji
RA   Petruk, Kenneth C.
RT   "Human glioma immunobiology in vitro: implications for immunogene
RT   therapy.";
RL   Neurosurgery 46:1169-1178(2000).
//
RX   PubMed=11950413; DOI=10.1097/00006123-200205000-00027;
RA   Parney, Ian Frederick
RA   Farr-Jones, Maxine A.
RA   Koshal, Anu
RA   Chang, Lung-Ji
RA   Petruk, Kenneth C.
RT   "Human brain tumor cell culture characterization after
RT   immunostimulatory gene transfer.";
RL   Neurosurgery 50:1094-1102(2002).
//
RX   PubMed=10448865; DOI=10.1023/A:1006115608103;
RA   Farr-Jones, Maxine A.
RA   Parney, Ian Frederick
RA   Petruk, Kenneth C.
RT   "Improved technique for establishing short term human brain tumor
RT   cultures.";
RL   J. Neurooncol. 43:1-10(1999).
//